ANIP — ANI PHARMACEUTICALS INC

Ownership history in Bayesian Capital Management, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in ANI PHARMACEUTICALS INC (ANIP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.22% (2025 Q3)
Avg. % of fund
0.11%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 11,500 +6,053 +111.1% 0.22% $1.1M $91.60
2025 Q1 REDUCED 5,447 -792 -12.7% 0.06% $365K $66.95
2024 Q3 INITIATED 6,239 — — 0.04% $372K $59.66
% of Fund (quarterly)    ANIP price (monthly, adj. close)

Other funds also holding ANIP

As of 2025 Q4 — sorted by position size

Global Alpha Capital Management Ltd. 3Y 7Y 2.84% APIS CAPITAL ADVISORS, LLC 3Y 7Y 2.7% Ranger Investment Management, L.P. 3Y 7Y 1.96% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 1.88% Soleus Capital Management, L.P. 3Y 1.42% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.18% Parkman Healthcare Partners LLC 3Y 1.09% Sio Capital Management, LLC 3Y 7Y 1.08% Penn Capital Management Company, LLC 3Y 7Y 0.87% Deep Track Capital, LP 3Y 0.67%
← Back to Bayesian Capital Management, LP Holdings